Multiply by five. That is the general formula for computing the price of a prescription drug in the United States, versus what it costs in the rest of the world.
That is one of the starker findings in a year-end report on prescription drugs prepared by Oregon's Department of Consumer and Business Services (DCBS). The report is one of the requirements of a prescription drug price transparency program created by the legislature two years ago. Cassie Soucy, who manages the program at DCBS, fleshes out some of the details.